<\/p>\n
T\u00fcrk Kalp ve Damar Cerrahisi Derne\u011fi Ba\u015fkan\u0131 Prof. Dr. K\u00fcr\u015fat Bozkurt, T\u00fcrkiye’nin yapay kalp uygulamalar\u0131nda ve robotik kalp cerrahisinde Avrupa’da 2’nci s\u0131rada oldu\u011funu s\u00f6yledi.<\/p>\n
Prof. Dr. Bozkurt, 10-16 Nisan Kalp Sa\u011fl\u0131\u011f\u0131 Haftas\u0131 dolay\u0131s\u0131yla AA muhabirine yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, kalp ve damar rahats\u0131zl\u0131klar\u0131n\u0131n en s\u0131k g\u00f6r\u00fclen hastal\u0131klar i\u00e7inde yer ald\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
T\u00fcrkiye’de hastal\u0131k s\u0131kl\u0131\u011f\u0131n\u0131n geli\u015fmi\u015f \u00fclkelerle benzer oranlarda oldu\u011funu ifade eden Bozkurt, “Say\u0131sal olarak verilere bak\u0131ld\u0131\u011f\u0131nda \u00fclkemizde 30 ila 79 ya\u015f aras\u0131nda her 1000 ki\u015fiden 15’inde \u015fah damar\u0131 daralmas\u0131 bulunuyor. Kontrol, takip ve bir k\u0131sm\u0131na m\u00fcdahale edilmesi gerekiyor. Bu n\u00fcfus say\u0131s\u0131na g\u00f6re hesaplan\u0131rsa T\u00fcrkiye’de yakla\u015f\u0131k 600 binden fazla ki\u015finin ge\u00e7ici ya da kal\u0131c\u0131 fel\u00e7 riski bulunuyor.” dedi.<\/p>\n
Bozkurt, \u015fu bilgileri verdi:<\/p>\n
“65 ya\u015f \u00fcst\u00fc her 65 erkekten birinde mutlaka takip ve tedavi edilmesi gereken aort damar\u0131 geni\u015flemesi bulunuyor. Her y\u0131l 100 binden fazla ki\u015fi de bacak toplar damar\u0131 p\u0131ht\u0131s\u0131 ya da akci\u011fere p\u0131ht\u0131 atmas\u0131 s\u00f6z konusu. Her y\u0131l 25 bin hastaya b\u00f6brek hastal\u0131\u011f\u0131 nedeniyle diyaliz ihtiyac\u0131na ba\u011fl\u0131 fist\u00fcl a\u00e7\u0131lmas\u0131 gerekiyor.<\/p>\n
Bu say\u0131lar mevcut hastalar\u0131 de\u011fil, her y\u0131l geli\u015fen yeni hastalar\u0131n say\u0131s\u0131n\u0131 kaps\u0131yor. \u00d6rne\u011fin, an itibar\u0131yla her 100 ki\u015fiden 4’\u00fc takip ya da tedavi edilmesi gereken koroner arter hastas\u0131. Kapak hastal\u0131klar\u0131, aort damar\u0131n\u0131n di\u011fer hastal\u0131klar\u0131, do\u011fu\u015ftan gelen kalp damar hastal\u0131klar\u0131n\u0131n hepsi dahil edildi\u011finde ise her 8 ki\u015fiden birinde \u00e7e\u015fitli kalp veya damar hastal\u0131\u011f\u0131 var. Toplumda her 8 ki\u015fiden birinin kalp ve damar sa\u011fl\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan konunun uzman\u0131na gitmesi, takipte ve tedavi olmas\u0131 gereken bir hastal\u0131\u011f\u0131 s\u00f6z konusu.”<\/p>\n
Prof. Dr. Bozkurt, koroner hastal\u0131klar\u0131n tedavisinde stent uygulamas\u0131n\u0131n hala \u00f6nemli bir yer tuttu\u011funu aktararak, “Her hasta i\u00e7in stent en uygun \u00e7\u00f6z\u00fcm olmayabiliyor. Y\u0131lda yakla\u015f\u0131k 70 bin hastaya koroner baypas ameliyat\u0131 yap\u0131l\u0131yor. Bacak damar\u0131 p\u0131ht\u0131s\u0131 varl\u0131\u011f\u0131nda kapal\u0131 y\u00f6ntemle p\u0131ht\u0131y\u0131 eritmek gittik\u00e7e yayg\u0131nla\u015f\u0131yor. Robotik kalp cerrahisi, kalp akci\u011fer makinalar\u0131ndaki geli\u015fim, yapay kalpler son 10 y\u0131lda kalp cerrahisinde ciddi de\u011fi\u015fimler yaratt\u0131.” dedi.<\/p>\n
T\u00fcrkiye’de kalp damar cerrahisinde geli\u015fmi\u015f \u00fclkelerdeki her operasyonun ba\u015far\u0131l\u0131 bir \u015fekilde yap\u0131ld\u0131\u011f\u0131na dikkati \u00e7eken Bozkurt, “Yapay kalp uygulamalar\u0131nda ve robotik kalp cerrahisinde Avrupa’da 2’nci s\u0131raday\u0131z. Avrupa’da bu iki alanda birinci olan \u00fclke ise Almanya.” diye konu\u015ftu.<\/p>\n
Bozkurt, hastalarda kalbin tedavi kapsam\u0131nda y\u00fcksek teknolojik cihazlarla desteklenebildi\u011fini belirterek, yapay kalp destek cihazlar\u0131n\u0131n, son evre kalp yetersizli\u011findeki hastada kalbin pompalama g\u00f6revini \u00fcstlenen, ileri teknoloji \u00fcr\u00fcn\u00fc cihazlar olarak tan\u0131mland\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
Hastalar\u0131n uzun y\u0131llar kullanabilece\u011fi uzun d\u00f6nem mekanik destek cihazlar\u0131n\u0131n yan\u0131 s\u0131ra “\u015fok” diye ifade edilen akut kalp yetmezli\u011fi durumlar\u0131nda ise kalp yetersizli\u011fi d\u00fczelene ya da kalp nakli oluncaya kadar hastan\u0131n hayatta kalmas\u0131 i\u00e7in k\u0131sa s\u00fcreli kullan\u0131labilen kalp destek cihazlar\u0131n\u0131n da uyguland\u0131\u011f\u0131 bilgisini veren Bozkurt, \u00f6zellikle Kovid-19 salg\u0131n\u0131 d\u00f6neminde bir\u00e7ok hastan\u0131n tekrar hayata d\u00f6nmesinde bu cihazlar\u0131n b\u00fcy\u00fck katk\u0131 sa\u011flad\u0131\u011f\u0131n\u0131 aktard\u0131.<\/p>\n
Bozkurt, yapay kalp destek cihaz\u0131 operasyonlar\u0131n\u0131n hastan\u0131n durumuna g\u00f6re de\u011fi\u015fmekle birlikte, genellikle ortalama 5 saat s\u00fcrd\u00fc\u011f\u00fcn\u00fc belirterek, operasyonun ard\u0131ndan hastan\u0131n yo\u011fun bak\u0131ma al\u0131narak takip edildi\u011fini ifade etti.<\/p>\n
Hastan\u0131n yakla\u015f\u0131k 20-25 g\u00fcn hastanede takip alt\u0131nda tutuldu\u011funu aktaran Bozkurt, “\u00dclkemizde her y\u0131l ileri d\u00f6nem kalp yetmezli\u011fi bulunan 200’den fazla hasta, toplumda ‘yapay kalp’ diye bilinen mekanik kalp destek cihaz\u0131 ile normal hayat\u0131na geri d\u00f6n\u00fcyor. T\u00fcrkiye’de bug\u00fcne kadar 2 bin civar\u0131nda hastaya bu kalp destek sistemi tak\u0131ld\u0131. Y\u0131ll\u0131k kalp nakli say\u0131s\u0131 ise 50-60 civar\u0131nda.” bilgisini verdi.<\/p>\n
Bozkurt, yapay kalp ile hastalar\u0131n g\u00fcnl\u00fck hayatlar\u0131n\u0131 devam ettirebildi\u011fine dikkati \u00e7ekerek, “Yapay kalp deste\u011fi alan hastalar\u0131n, bu s\u00fcre\u00e7te di\u011fer organlar\u0131 da toparlanmaktad\u0131r ve ki\u015fi daha sa\u011fl\u0131kl\u0131 olarak kalp nakli aday\u0131 olmaktad\u0131r.” dedi.<\/p>\n
Robotik cerrahinin de hasta i\u00e7in \u00f6nemli avantajlar sa\u011flad\u0131\u011f\u0131n\u0131 dile getiren Bozkurt, k\u00fc\u00e7\u00fck kesi y\u00f6nteminden daha k\u00fc\u00e7\u00fck kesiler ile yap\u0131lan robotik ameliyatlarda g\u00f6\u011fs\u00fcn \u00f6n duvar\u0131ndaki kemik kesilmedi\u011fi i\u00e7in g\u00f6\u011f\u00fcs duvar\u0131n\u0131n b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn korundu\u011funu aktard\u0131.<\/p>\n
Bozkurt, bu y\u00f6ntemle ameliyat sonras\u0131 hastalarda solunum sistemi problemlerinin \u00e7ok daha az g\u00f6r\u00fcld\u00fc\u011f\u00fcn alt\u0131n\u0131 \u00e7izerek, “Kanama miktar\u0131 \u00e7ok d\u00fc\u015f\u00fck oldu\u011fundan, hastaya kan nakline gerek kalmayabilir ve ola\u011fan\u00fcst\u00fc bir durum s\u00f6z konusu olmad\u0131\u011f\u0131nda hasta yo\u011fun bak\u0131mda bir, serviste 4 g\u00fcn kald\u0131ktan sonra taburcu edilebilir. Klasik a\u00e7\u0131k ameliyatlarda kemi\u011fin kaynama s\u00fcresi daha uzun s\u00fcrmektedir.” dedi.<\/p>\n
Erken te\u015fhisin her hastal\u0131kta oldu\u011fu gibi kalp ve damar hastal\u0131klar\u0131 a\u00e7\u0131s\u0131ndan da b\u00fcy\u00fck \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 dile getiren Bozkurt, “Ki\u015finin sahip oldu\u011fu risk ya da hastal\u0131klar\u0131 bilmesi, bunlara kar\u015f\u0131 ya\u015fam tarz\u0131 de\u011fi\u015fikli\u011fi yapmas\u0131, geli\u015febilecek hayati tehlikelere kar\u015f\u0131 en \u00f6nemli \u00e7\u0131k\u0131\u015f noktas\u0131d\u0131r. Risk fakt\u00f6rlerini azaltmak, kalp ve damar hastal\u0131klar\u0131n\u0131n \u00f6nlenmesi a\u00e7\u0131s\u0131ndan hayat kurtar\u0131c\u0131d\u0131r. Beslenme al\u0131\u015fkanl\u0131\u011f\u0131 ve uygun fiziksel aktiviten risk fakt\u00f6rlerinin azalt\u0131lmas\u0131nda faydal\u0131d\u0131r.” de\u011ferlendirmesinde bulundu.<\/p>\n
Kalp hastal\u0131klar\u0131 i\u00e7in tedavi karar\u0131n\u0131n kardiyologlar ve kalp damar cerrahlar\u0131ndan olu\u015fan ekip taraf\u0131ndan verildi\u011fini anlatan Bozkurt, stent, ameliyat, kas\u0131ktan giri\u015fimle kapak de\u011fi\u015fimi gibi uygulamalar\u0131n hepsinin fayda ve riskler i\u00e7eren i\u015flemler oldu\u011funa i\u015faret etti.<\/p>\n
Bozkurt, “Hasta i\u00e7in erken d\u00f6nem fayda, i\u015flem riski, uzun d\u00f6nem sonu\u00e7lar bunlar\u0131 ortak ak\u0131lla de\u011ferlendiren ve hasta i\u00e7in en iyi tedavinin ne olaca\u011f\u0131na karar veren ekip kalp ekibidir. Bu, t\u00fcm geli\u015fmi\u015f \u00fclkelerde uygulanan standart y\u00f6ntemdir. O nedenle koroner ya da kapak hastal\u0131\u011f\u0131 olanlara, stent veya ameliyat gerekti\u011finde kalp ekibi taraf\u0131ndan g\u00f6r\u00fc\u015f almas\u0131n\u0131 tavsiye ediyoruz.” diye konu\u015ftu.<\/p>\n